| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/05/2012 | WO2012001540A2 Building window structure |
| 01/05/2012 | WO2012001407A1 Capture of micro-organisms |
| 01/05/2012 | WO2012001378A1 Detection and quantification of vitamin d metabolites using an alkylamine to form stable adducts for mass spectrometric analysis |
| 01/05/2012 | WO2012001370A1 Method for diagnosing lung cancer |
| 01/05/2012 | WO2012001351A1 Hand-held test meter with deep power conservation mode |
| 01/05/2012 | WO2012001241A1 Functionalized films, sensory films, biosensors and methods for manufacturing them |
| 01/05/2012 | WO2012001178A1 The role of fragile x mental retardation gene and protein in cancer metastasis |
| 01/05/2012 | WO2012001142A1 Improved antibody binding affinity ligands |
| 01/05/2012 | WO2012001103A1 Histone citrullinated peptides and uses thereof |
| 01/05/2012 | WO2012001098A1 Diagnostic assay for type 1 diabetes |
| 01/05/2012 | WO2012001090A1 Test cell for assessing a well fluid |
| 01/05/2012 | WO2012001073A2 Improved method for selecting high producing cell lines |
| 01/05/2012 | WO2012001063A1 Dye compositions and dye syntheses |
| 01/05/2012 | WO2012001050A1 Dye compositions and dye syntheses |
| 01/05/2012 | WO2012000976A1 Method for diagnosis of bladder cancer and related kits |
| 01/05/2012 | WO2012000906A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 01/05/2012 | WO2012000866A1 11c-labelled peptide for detecting a diseased tissue |
| 01/05/2012 | WO2012000865A1 11c-marked peptide for detecting a tumor that expresses an her2/neu receptor |
| 01/05/2012 | WO2012000863A1 Aptamer complex for detecting a diseased tissue |
| 01/05/2012 | WO2012000862A1 11c-labelled peptide for detecting a diseased tissue |
| 01/05/2012 | WO2012000861A1 11c-labelled aptamer for detecting a diseased tissue |
| 01/05/2012 | WO2012000770A1 Methods to diagnose liver diseases |
| 01/05/2012 | WO2012000552A1 Water analysis sensor cartridge with transport container |
| 01/05/2012 | WO2012000539A1 An industrial robot transmission system, and industrial robot and a method for absorbing moisture |
| 01/05/2012 | WO2012000521A1 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid |
| 01/05/2012 | WO2012000119A1 A method of determining a predisposition to atrial fibrillation in a subject |
| 01/05/2012 | WO2012000095A1 Methods of kinome analysis |
| 01/05/2012 | WO2012000094A1 REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-α |
| 01/05/2012 | WO2012000062A1 Diagnosis and treatment of brain tumors |
| 01/05/2012 | WO2011143048A3 Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
| 01/05/2012 | WO2011143044A3 A lytic reagent system for flow cytometric analysis of leukocytes based on morphology or immunophenotypes |
| 01/05/2012 | WO2011142858A3 Chlorotoxin variants, conjugates, and methods for their use |
| 01/05/2012 | WO2011142836A9 Assays for the detection of genotype, mutations, and/or aneuploidy |
| 01/05/2012 | WO2011141824A3 Methods for identifying nmda receptor modulators |
| 01/05/2012 | WO2011141612A3 Method for the diagnosis/prognosis of colorectal cancer |
| 01/05/2012 | WO2011138705A3 Sensing device for detecting a substance in a fluid |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | WO2011113017A3 Methods for predicting fouling tendencies of hydrocarbon containing feedstocks |
| 01/05/2012 | WO2011112894A3 Optical particle characterization system |
| 01/05/2012 | WO2011109364A3 Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| 01/05/2012 | WO2011106536A9 Methods of diagnosing infectious disease pathogens and their drug sensitivity |
| 01/05/2012 | WO2011106057A3 Nanostructure biosensors and systems and methods of use thereof |
| 01/05/2012 | WO2011104531A3 Clostridium gene |
| 01/05/2012 | WO2011100708A3 Assay card for sample acquisition, treatment and reaction |
| 01/05/2012 | WO2011100458A3 Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
| 01/05/2012 | WO2011100192A3 Radioiodine-labeled thyroxine dosimetry, and methods of use thereof |
| 01/05/2012 | WO2011096763A3 Kit including sequence specific binding protein and method and device for determining nucleotide sequence of target nucleic acid |
| 01/05/2012 | WO2011094593A3 Novel lowered affinity antibodies and methods of marking the same |
| 01/05/2012 | WO2011087766A3 Methods for assessing er stress |
| 01/05/2012 | WO2011081366A9 Beef-specific age determination marker containing the p21 protein |
| 01/05/2012 | WO2011033322A3 Crystal structure |
| 01/05/2012 | WO2010127275A8 Method of expanding human hepatocytes in vivo |
| 01/05/2012 | WO2009140679A9 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120005765 Animal model for parkinson's disease |
| 01/05/2012 | US20120004857 Throughput information generating apparatus of sample analyzer, sample analyzer, throughput information generating method of sample analyzer, and computer program product |
| 01/05/2012 | US20120004854 Metabolic biomarkers for ovarian cancer and methods of use thereof |
| 01/05/2012 | US20120004512 Method, System, and Computer Program Product For The Evaluation of Glycemic Control in Diabetes From Self-Monitoring Data |
| 01/05/2012 | US20120004289 Annexin a11 and associated genes as biomarkers for cancer |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004254 G protein-coupled receptor antagonist and its use for preventing and treating alzheimer's disease |
| 01/05/2012 | US20120004205 Il-13 induced gene signature for eosinophilic esophagitis |
| 01/05/2012 | US20120004186 Platelet aggregation inhibitor composition |
| 01/05/2012 | US20120004185 Polypeptide structural motifs associated with cell signaling activity |
| 01/05/2012 | US20120004178 Biglycan mutants and related therapeutics and methods of use |
| 01/05/2012 | US20120004175 Inhibitors of nf-kb activity |
| 01/05/2012 | US20120004169 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120004143 Integrated cartridge |
| 01/05/2012 | US20120004141 Amplified bioassay |
| 01/05/2012 | US20120004136 Msh2 and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer |
| 01/05/2012 | US20120004133 Method for the diagnosis of age-associated vascular disorders |
| 01/05/2012 | US20120004132 Detection of Nucleic Acids and Proteins |
| 01/05/2012 | US20120004131 Microarrays and uses therefor |
| 01/05/2012 | US20120004130 Autoimmune disease biomarkers |
| 01/05/2012 | US20120004129 Biomarkers for inhibitors with anti-angiogenic activity |
| 01/05/2012 | US20120004122 Diagnostic Marker for Migraine and Use Thereof |
| 01/05/2012 | US20120004121 Diagnostic Assay For Source of Inflammation |
| 01/05/2012 | US20120004120 Self-encoding sensor with microspheres |
| 01/05/2012 | US20120004119 Gene expression markers of oncolytic virus sensitivity |
| 01/05/2012 | US20120004118 Methods for the subclassification of breast tumours |
| 01/05/2012 | US20120004117 Diagnosis and treatment of cancer using anti-tm4sf20 antibody |
| 01/05/2012 | US20120003756 Chromatographic assay system |
| 01/05/2012 | US20120003754 Methods, products and treatments for diabetes |
| 01/05/2012 | US20120003752 Prognostic biomarkers for the progression of primary chronic kidney disease |
| 01/05/2012 | US20120003749 Nucleic acid molecule capable of binding to 2,4,6-trinitrophenyl skeleton, method for detecting compound having 2,4,6-trinitrophenyl skeleton using the nucleic acid molecule, and use of the nucleic acid molecule |
| 01/05/2012 | US20120003748 Chemical Ionization Reaction or Proton Transfer Reaction Mass Spectrometry |
| 01/05/2012 | US20120003746 Method and kit for identification of an explosive substance which contains an oxidant |
| 01/05/2012 | US20120003745 Method for measuring physiologically active substance of biological origin, program for implementing the same, and apparatus for measuring physiologically active substance of biological origin |
| 01/05/2012 | US20120003696 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 01/05/2012 | US20120003674 Chloral Hydrate Detection |
| 01/05/2012 | US20120003673 Screening method, composition containing substance selected by the screening method, and binding substance |
| 01/05/2012 | US20120003672 In vitro-method for the diagnosis, prognosis, monitoring and therapy follow-up of disorders associated with the metabolic syndrome, a cardiovascular disease and/or insulin resistance |
| 01/05/2012 | US20120003671 Methods for antibody engineering |
| 01/05/2012 | US20120003670 Methods and Kits for Measuring Von Willebrand Factor |
| 01/05/2012 | US20120003669 Immunohistochemical staining method and immunohistochemical staining apparatus |
| 01/05/2012 | US20120003667 Electrophoretic tag-based in vitro assay to quantify dimerization of p66 and p51 sub-units of hiv-1 reverse transcriptase (rt) |
| 01/05/2012 | US20120003666 Method of detecting target substance |
| 01/05/2012 | US20120003665 Dissolved Protein Arthritis Markers |
| 01/05/2012 | US20120003664 Method for evaluating pre-treatment |